Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

MIF and D-DT are potential disease severity modifiers in male MS subjects.

Benedek G, Meza-Romero R, Jordan K, Zhang Y, Nguyen H, Kent G, Li J, Siu E, Frazer J, Piecychna M, Du X, Sreih A, Leng L, Wiedrick J, Caillier SJ, Offner H, Oksenberg JR, Yadav V, Bourdette D, Bucala R, Vandenbark AA.

Proc Natl Acad Sci U S A. 2017 Sep 18. pii: 201712288. doi: 10.1073/pnas.1712288114. [Epub ahead of print]

PMID:
28923927
2.

Association of the macrophage migration inhibitory factor promoter polymorphisms with benign lymphoepithelial lesion of lacrimal gland.

Li QJ, Zhao PX, Zhang XJ, Yi Y, Cheng DY, Ma JM, Ma XM.

Int J Ophthalmol. 2017 Aug 18;10(8):1229-1232. doi: 10.18240/ijo.2017.08.07. eCollection 2017.

3.

The increased concentration of macrophage migration inhibitory factor in serum and cerebrospinal fluid of patients with tick-borne encephalitis.

Grygorczuk S, Parczewski M, Świerzbińska R, Czupryna P, Moniuszko A, Dunaj J, Kondrusik M, Pancewicz S.

J Neuroinflammation. 2017 Jun 24;14(1):126. doi: 10.1186/s12974-017-0898-2.

4.

Macrophage migration inhibitory factor promoter polymorphisms (-794 CATT5-8): Relationship with soluble MIF levels in coronary atherosclerotic disease subjects.

Qian L, Wang XY, Thapa S, Tao LY, Wu SZ, Luo GJ, Wang LP, Wang JN, Wang J, Li J, Tang JF, Ji KT.

BMC Cardiovasc Disord. 2017 Jun 2;17(1):144. doi: 10.1186/s12872-017-0570-x.

5.

Plasma Levels of Macrophage Migration Inhibitory Factor and d-Dopachrome Tautomerase Show a Highly Specific Profile in Early Life.

Roger T, Schlapbach LJ, Schneider A, Weier M, Wellmann S, Marquis P, Vermijlen D, Sweep FC, Leng L, Bucala R, Calandra T, Giannoni E.

Front Immunol. 2017 Jan 25;8:26. doi: 10.3389/fimmu.2017.00026. eCollection 2017.

6.

Evaluation of MIF -173 G/C Polymorphism in Turkish Patients with Ankylosing Spondylitis.

Gürel Ç, İnanır A, Nursal AF, Tekcan A, Rüstemoğlu A, Yigit S.

Balkan Med J. 2016 Nov;33(6):614-619. Epub 2016 Nov 1.

7.

MIF allele-dependent regulation of the MIF coreceptor CD44 and role in rheumatoid arthritis.

Yoo SA, Leng L, Kim BJ, Du X, Tilstam PV, Kim KH, Kong JS, Yoon HJ, Liu A, Wang T, Song Y, Sauler M, Bernhagen J, Ritchlin CT, Lee P, Cho CS, Kim WU, Bucala R.

Proc Natl Acad Sci U S A. 2016 Dec 6;113(49):E7917-E7926. Epub 2016 Nov 21.

8.

A Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Autoimmune Hepatitis Severity in US and Japanese Patients.

Assis DN, Takahashi H, Leng L, Zeniya M, Boyer JL, Bucala R.

Dig Dis Sci. 2016 Dec;61(12):3506-3512. Epub 2016 Oct 1.

PMID:
27696094
9.

Macrophage migration inhibitory factor -173 G/C polymorphism is associated with an increased risk of pulmonary tuberculosis in Zahedan, Southeast Iran.

Hashemi M, Sharifi-Mood B, Rasouli A, Amininia S, Naderi M, Taheri M.

EXCLI J. 2015 Jan 21;14:117-22. doi: 10.17179/excli2014-636. eCollection 2015.

10.

Impact of MIF Gene Promoter Variations on Risk of Rheumatic Heart Disease and Its Age of Onset in Saudi Arabian Patients.

Abdallah AM, Al-Mazroea AH, Al-Harbi WN, Al-Harbi NA, Eldardear AE, Almohammadi Y, Al-Harbi KM.

Front Immunol. 2016 Mar 14;7:98. doi: 10.3389/fimmu.2016.00098. eCollection 2016.

11.

Plasma and Synovial Fluid TrxR Levels are Correlated With Disease Risk and Severity in Patients With Rheumatoid Arthritis.

Xie Z, Sun J, Li H, Shao T, Wang D, Zheng Q, Wen C.

Medicine (Baltimore). 2016 Feb;95(6):e2543. doi: 10.1097/MD.0000000000002543.

12.

High expression levels of macrophage migration inhibitory factor sustain the innate immune responses of neonates.

Roger T, Schneider A, Weier M, Sweep FC, Le Roy D, Bernhagen J, Calandra T, Giannoni E.

Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):E997-1005. doi: 10.1073/pnas.1514018113. Epub 2016 Feb 8.

13.

MIF Gene Polymorphism rs755622 Is Associated With Coronary Artery Disease and Severity of Coronary Lesions in a Chinese Kazakh Population: A Case-Control Study.

Luo JY, Xu R, Li XM, Zhou Y, Zhao Q, Liu F, Chen BD, Ma YT, Gao XM, Yang YN.

Medicine (Baltimore). 2016 Jan;95(4):e2617. doi: 10.1097/MD.0000000000002617.

14.

Transcription factor ICBP90 regulates the MIF promoter and immune susceptibility locus.

Yao J, Leng L, Sauler M, Fu W, Zheng J, Zhang Y, Du X, Yu X, Lee P, Bucala R.

J Clin Invest. 2016 Feb;126(2):732-44. doi: 10.1172/JCI81937. Epub 2016 Jan 11.

15.

MIF: Implications in the Pathoetiology of Systemic Lupus Erythematosus.

Lang T, Foote A, Lee JP, Morand EF, Harris J.

Front Immunol. 2015 Nov 11;6:577. doi: 10.3389/fimmu.2015.00577. eCollection 2015. Review.

16.

Macrophage migration inhibitory factor promoter polymorphisms (-794 CATT 5-8 and -173 G>C): relationship with mRNA expression and soluble MIF levels in young obese subjects.

Matia-García I, Salgado-Goytia L, Muñoz-Valle JF, García-Arellano S, Hernández-Bello J, Salgado-Bernabé AB, Parra-Rojas I.

Dis Markers. 2015;2015:461208. doi: 10.1155/2015/461208. Epub 2015 Apr 20.

17.

Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis.

Gu R, Santos LL, Ngo D, Fan H, Singh PP, Fingerle-Rowson G, Bucala R, Xu J, Quinn JM, Morand EF.

Cytokine. 2015 Apr;72(2):135-45. doi: 10.1016/j.cyto.2014.11.015. Epub 2015 Jan 31.

18.

Macrophage migration inhibitory factor (MIF) promoter polymorphisms (-794 CATT5-8 and -173 G>C): association with MIF and TNFα in psoriatic arthritis.

Morales-Zambrano R, Bautista-Herrera LA, De la Cruz-Mosso U, Villanueva-Quintero GD, Padilla-Gutiérrez JR, Valle Y, Parra-Rojas I, Rangel-Villalobos H, Gutiérrez-Ureña SR, Muñoz-Valle JF.

Int J Clin Exp Med. 2014 Sep 15;7(9):2605-14. eCollection 2014.

19.

Association between the -794 (CATT)5-8  MIF gene polymorphism and susceptibility to acute coronary syndrome in a western Mexican population.

Valdés-Alvarado E, Muñoz-Valle JF, Valle Y, Sandoval-Pinto E, García-González IJ, Valdez-Haro A, De la Cruz-Mosso U, Flores-Salinas HE, Padilla-Gutiérrez JR.

J Immunol Res. 2014;2014:704854. doi: 10.1155/2014/704854. Epub 2014 Jul 3.

20.

Macrophage migration inhibitory factor inhibits the antiinflammatory effects of glucocorticoids via glucocorticoid-induced leucine zipper.

Fan H, Kao W, Yang YH, Gu R, Harris J, Fingerle-Rowson G, Bucala R, Ngo D, Beaulieu E, Morand EF.

Arthritis Rheumatol. 2014 Aug;66(8):2059-70. doi: 10.1002/art.38689.

Supplemental Content

Support Center